CLINICAL TRIAL: TOBACCO SMOKE INDUCED CELL INJURY IN LUNG COMPARTMENTS
临床试验:烟草烟雾引起的肺室细胞损伤
基本信息
- 批准号:7717092
- 负责人:
- 金额:$ 2.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-12-01 至 2008-11-30
- 项目状态:已结题
- 来源:
- 关键词:Alveolar MacrophagesBiopsyBlood TestsBronchoscopyChronic Obstructive Airway DiseaseClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDevelopmentFundingGrantInstitutionLungLung Lavage FluidMediatingNitric OxideOxidantsPilot ProjectsProductionPulmonary function testsResearchResearch PersonnelResourcesRoleSmokeSourceStructure of parenchyma of lungTobacco smokeTranscriptional ActivationUnited States National Institutes of HealthUp-Regulationalpha 1-Antitrypsinalpha 1-Antitrypsin Deficiencycell injuryconcepthealthy volunteerlung injurynovelprevent
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Determining the role of tobacco smoke (TS) induced alveolar macrophage (AM) mediated lung injury and the protective role of alpha 1-antitrypsin (AAT) in modulating the extent of lung injury caused by TS may allow for the development of more specific therapies to prevent or reduce the lung damage. AM are a source of nitric oxide (NO) through up-regulation of iNOS. NO production may continue long after the initial insult (TS) has been eliminated. The concept that AAT may function to inhibit oxidant damage, such as iNOS, to the lung tissue is novel and the subject of this project. This is a pilot project with 20 subjects undergoing bronchoscopy. Bronchial lavage fluid, biopsy/brushings, pulmonary function testing and research blood tests will be compared in four subject groups?healthy volunteers who smoke, healthy volunteers who do not smoke, subjects with documented chronic obstructive pulmonary disease (COPD) and subjects with alpha 1-antitrypsin deficiency (AATD).
这个子项目是众多研究子项目之一
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK Louis BRANTLY其他文献
MARK Louis BRANTLY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK Louis BRANTLY', 18)}}的其他基金
ALPHA-1 ANTITRYPSIN AND MACROPHAGE FUNCTION
ALPHA-1 抗胰蛋白酶和巨噬细胞功能
- 批准号:
7950744 - 财政年份:2008
- 资助金额:
$ 2.49万 - 项目类别:
CLINICAL TRIAL: PHASE 3 STUDY OF SAFETY AND EFFICACY OF PIRFENIDONE IN PATIENTS
临床试验:吡非尼酮对患者安全性和有效性的第 3 阶段研究
- 批准号:
7950737 - 财政年份:2008
- 资助金额:
$ 2.49万 - 项目类别:
CLINICAL TRIAL: PHASE I TRIAL OF INTRAMUSCULAR INJECTION OF RAAV1-CB-HAAT
临床试验:RAAV1-CB-HAAT 肌内注射 I 期试验
- 批准号:
7950715 - 财政年份:2008
- 资助金额:
$ 2.49万 - 项目类别:
PIRFENIDONE AND PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF)
吡非尼酮和特发性肺纤维化 (IPF) 患者
- 批准号:
7950773 - 财政年份:2008
- 资助金额:
$ 2.49万 - 项目类别:
CLINICAL TRIAL: TOBACCO SMOKE INDUCED CELL INJURY IN LUNG COMPARTMENTS
临床试验:烟草烟雾引起的肺室细胞损伤
- 批准号:
7950714 - 财政年份:2008
- 资助金额:
$ 2.49万 - 项目类别:
CLINICAL TRIAL: PHASE I TRIAL OF INTRAMUSCULAR INJECTION OF RAAV1-CB-HAAT
临床试验:RAAV1-CB-HAAT 肌内注射 I 期试验
- 批准号:
7717093 - 财政年份:2007
- 资助金额:
$ 2.49万 - 项目类别:
相似海外基金
卵巣癌/子宮体癌における薬剤感受性メチル化診断キットの開発とLiquid Biopsyへの応用
卵巢癌/子宫内膜癌药物敏感甲基化诊断试剂盒的研制及其在液体活检中的应用
- 批准号:
24K02584 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
グリオーマのliquid biopsyによるメチル化網羅的解析とprecision medicineへの応用
胶质瘤液体活检甲基化综合分析及其在精准医疗中的应用
- 批准号:
24K12271 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis (MONALISA)
SIOPEN 通过液体活检敏感性分析 (MONALISA) 监测神经母细胞瘤复发的实用临床试验
- 批准号:
10110442 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
EU-Funded
MONALISA: A SIOPEN pragmatic clinical trial to MOnitor NeuroblastomA relapse with LIquid biopsy Sensitive Analysis
MONALISA:一项 SIOPEN 实用临床试验,通过液体活检监测神经母细胞瘤复发 敏感性分析
- 批准号:
10103126 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
EU-Funded
精神的長期ストレス児童の口腔細菌叢と唾液成分の解析:唾液 liquid biopsyを目指して
长期精神应激儿童口腔菌群和唾液成分分析:唾液液体活检
- 批准号:
24K13206 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Liquid biopsyを用いた炎症性腸疾患の早期診断法開発
液体活检炎症性肠病早期诊断方法的开发
- 批准号:
24K10595 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Mutated human oncogene recombinant nucleosomes as reference materials for liquid biopsy
突变人癌基因重组核小体作为液体活检参考材料
- 批准号:
10090714 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
Collaborative R&D
肝細胞癌における術中門脈血を用いたliquid biopsyの検討
肝细胞癌术中门静脉血液体活检检查
- 批准号:
24K19404 - 财政年份:2024
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Genetic diagnosis of vascular malformations by liquid biopsy and its application to precision medicine
液体活检对血管畸形的基因诊断及其在精准医疗中的应用
- 批准号:
23K09072 - 财政年份:2023
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Breath biopsy technology targeting for volatile oxidized lipids
针对挥发性氧化脂质的呼吸活检技术
- 批准号:
23K06080 - 财政年份:2023
- 资助金额:
$ 2.49万 - 项目类别:
Grant-in-Aid for Scientific Research (C)